-
Breaking Down Barriers with GLP-1ᴿˣ: Noom’s New, Affordable Weight Loss Medication
- 2024/10/11
- 再生時間： 24 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Dr. Adonis Saremi, Noom's Chief Medical Officer, explains why Noom launched GLP-1ᴿˣ, an industry-first, affordable weight loss medication with a Taper-Off Guarantee.
Dr. Adonis and Dayo Akinrinade, Founder and GM at Noom Vibe, discuss how the new class of GLP-1 medications (such as Ozempic and Wegovy) is revolutionizing weight loss. Dr. Adonis emphasizes the affordability and accessibility challenges patients face in obtaining GLP-1s, along with real-world issues like poor persistence and loss of lean muscle mass.
This episode was recorded live on Noom Vibe, the free wellness community app from Noom. Noom Vibe makes building healthy habits fun and rewarding through a supportive community. Key features include an incentivized step and habit tracker, live conversations with coaches, and community connections. Noom Vibe is available now on the Apple App Store and Google Play.
To learn more, visit NoomVibe.com.
Curious about the basics of GLP-1 weight loss medications? Listen to this episode from the Noom Vibe podcast.